• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Tumor protein p63-regulated gene 1-like protein (TPRG1L)

ACP17047

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP17047 Target NameTPRG1L
Target SynonymsFAM79A; Mossy fiber terminal-associated vertebrate-specific presynaptic protein; MOVER; Protein FAM79A; TPRG1L; TPRGL_HUMAN; Tumor protein p63-regulated gene 1-like proteinFormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Expression Range1-272
Protein LengthFull length proteinPurity>85% (SDS-PAGE)
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ5T0D9
Background Information
  • Uniprot Id

    Q5T0D9

  • Target Species

    Human

  • Target Name

    TPRG1L

  • Target Full Name

    Tumor protein p63-regulated gene 1-like protein

  • Target Function

    Presynaptic protein involved in the synaptic transmission tuning. Regulates synaptic release probability by decreasing the calcium sensitivity of release.

  • Target Subcellular Location

    Cytoplasmic vesicle, secretory vesicle, synaptic vesicle membrane; Peripheral membrane protein. Cell junction, synapse, presynaptic active zone.

  • Target Protein Families

    TPRG1 family

  • Target Synonyms

    FAM79A; Mossy fiber terminal-associated vertebrate-specific presynaptic protein; MOVER; Protein FAM79A; TPRG1L; TPRGL_HUMAN; Tumor protein p63-regulated gene 1-like protein

Inquire Recombinant Human Tumor protein p63-regulated gene 1-like protein (TPRG1L) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification